These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 32472258

  • 1. Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?
    Khokhar MA, O'Beirne J.
    Dig Dis Sci; 2020 Nov; 65(11):3069-3071. PubMed ID: 32472258
    [No Abstract] [Full Text] [Related]

  • 2. [The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension].
    Fang DC, Chen L.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):244-6. PubMed ID: 19403016
    [No Abstract] [Full Text] [Related]

  • 3. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
    Song T, Rössle M, He F, Liu F, Guo X, Qi X.
    Dig Liver Dis; 2018 Apr; 50(4):323-330. PubMed ID: 29422242
    [Abstract] [Full Text] [Related]

  • 4. Hepatorenal syndrome: resolution after transjugular intrahepatic portosystemic shunt.
    Sturgis TM.
    J Clin Gastroenterol; 1995 Apr; 20(3):241-3. PubMed ID: 7797835
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic embolization of large spontaneous portosystemic shunts with transjugular intrahepatic portosystemic shunt (TIPS): A panacea for post-TIPS hepatic encephalopathy?
    Tripathi D, Bureau C.
    Hepatology; 2022 Sep; 76(3):551-553. PubMed ID: 35429167
    [No Abstract] [Full Text] [Related]

  • 6. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Sep; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 7. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.
    Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK.
    Hepatology; 1994 Jul; 20(1 Pt 1):46-55. PubMed ID: 8020904
    [Abstract] [Full Text] [Related]

  • 8. The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension.
    Hassoun Z, Pomier-Layrargues G.
    Eur J Gastroenterol Hepatol; 2004 Jan; 16(1):1-4. PubMed ID: 15095845
    [Abstract] [Full Text] [Related]

  • 9. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
    Krieger S, Jauss M, Jansen O, Stiehl A, Sauer P, Geissler M, Theilmann L, Krieger D.
    J Hepatol; 1997 Jul; 27(1):121-6. PubMed ID: 9252084
    [Abstract] [Full Text] [Related]

  • 10. Which approach is appropriate for spontaneous portosystemic shunt embolization in patients with post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy: Antegrade or retrograde?
    Wu W, Han G.
    Hepatology; 2016 Jul; 64(1):315-6. PubMed ID: 26566969
    [No Abstract] [Full Text] [Related]

  • 11. Transjugular intrahepatic portosystemic stent shunt for hepatorenal syndrome and ascites.
    Wong F.
    Digestion; 1998 Jul; 59 Suppl 2():41-4. PubMed ID: 9718418
    [No Abstract] [Full Text] [Related]

  • 12. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome.
    Brensing KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T.
    Lancet; 1997 Mar 08; 349(9053):697-8. PubMed ID: 9078203
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage.
    Jalan R, Elton RA, Redhead DN, Finlayson ND, Hayes PC.
    J Hepatol; 1995 Aug 08; 23(2):123-8. PubMed ID: 7499782
    [Abstract] [Full Text] [Related]

  • 14. Antegrade embolization of spontaneous splenorenal shunt for post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Doshi M, Pereira K, Carrion A, Martin P.
    Hepatology; 2016 Jul 08; 64(1):314-5. PubMed ID: 26566759
    [No Abstract] [Full Text] [Related]

  • 15. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M, Cholongitas E, Tibballs J, Burroughs A, Patch D.
    Eur J Gastroenterol Hepatol; 2006 Nov 08; 18(11):1143-50. PubMed ID: 17033432
    [Abstract] [Full Text] [Related]

  • 16. [30 Years of Transjugular Intrahepatic Portosystemic Shunt (TIPS): casting a retrospective glance and future perspectives].
    Schultheiß M, Bettinger D, Thimme R, Rössle M.
    Z Gastroenterol; 2020 Sep 08; 58(9):877-889. PubMed ID: 32947633
    [Abstract] [Full Text] [Related]

  • 17. Doppler ultrasound evaluation of transjugular intrahepatic portosystemic shunt function: pitfalls and artifacts.
    Wachsberg RH.
    Ultrasound Q; 2003 Sep 08; 19(3):139-48. PubMed ID: 14571161
    [Abstract] [Full Text] [Related]

  • 18. Judicious use of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt and renal blood flow.
    Cope C, Haskal ZJ.
    Radiology; 1995 Dec 08; 197(3):588. PubMed ID: 7480723
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P, Soussan J, Resseguier N, Botta-Fridlund D, Dufour JC, Gérolami R, Vidal V.
    Diagn Interv Imaging; 2016 Jun 08; 97(6):643-50. PubMed ID: 26947721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.